MedTrace Logo

Smoking Termination / Anxiety Reduction Treatment (ST/ART)

NCT01789125 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2019-04-23

No results posted yet for this study

Summary

The primary aim of this research study is to enhance smoking cessation outcome among smokers with anxiety disorders. The investigators are comparing two group treatment approaches: (1) An educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An integrated smoking cessation and anxiety treatment program (START). Both treatments also utilize nicotine replacement therapy.

Conditions

  • Smoking
  • Anxiety Disorders

Interventions

DRUG

Nicotine Patch

BEHAVIORAL

Smoking Termination and Anxiety Reduction Treatment

Integrated smoking cessation and anxiety reduction treatment

BEHAVIORAL

Education-Supportive Psychotherapy

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Houston

    lead OTHER

Principal Investigators

  • Michael J Zvolensky, Ph.D. · University of Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2015-12-31
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01789125 on ClinicalTrials.gov